⌘K

Home/Filings/4/0000899243-23-018043

4//SEC Filing

Bhatia Sangeeta N. 4

Accession 0000899243-23-018043

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 4:05 PM ET

Size

4.7 KB

Accession

0000899243-23-018043

Insider Transaction Report

Form 4

Period: 2023-08-09

VERTEX PHARMACEUTICALS INC / MAVRTX

Bhatia Sangeeta N.

Director

Transactions

Sale
Common Stock
2023-08-09$345.51/sh−242$83,613→ 4,386 total

Footnotes (1)

[F1]Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001643921

Filing Metadata

Form type: 4
Filed: Aug 10, 8:00 PM ET
Accepted: Aug 11, 4:05 PM ET
Size: 4.7 KB

View on SEC.gov